Computing and Information Systems - Research Publications

Permanent URI for this collection

Search Results

Now showing 1 - 10 of 30
  • Item
    Thumbnail Image
    EURO-WABB: an EU rare diseases registry for Wolfram syndrome, Alstrom syndrome and Bardet-Biedl syndrome
    Farmer, A ; Ayme, S ; de Heredia, ML ; Maffei, P ; McCafferty, S ; Mlynarski, W ; Nunes, V ; Parkinson, K ; Paquis-Flucklinger, V ; Rohayem, J ; Sinnott, R ; Tillmann, V ; Tranebaerg, L ; Barrett, TG (BMC, 2013-08-27)
    BACKGROUND: Wolfram, Alström and Bardet-Biedl (WABB) syndromes are rare diseases with overlapping features of multiple sensory and metabolic impairments, including diabetes mellitus, which have caused diagnostic confusion. There are as yet no specific treatments available, little or no access to well characterized cohorts of patients, and limited information on the natural history of the diseases. We aim to establish a Europe-wide registry for these diseases to inform patient care and research. METHODS: EURO-WABB is an international multicenter large-scale observational study capturing longitudinal clinical and outcome data for patients with WABB diagnoses. Three hundred participants will be recruited over 3 years from different sites throughout Europe. Comprehensive clinical, genetic and patient experience data will be collated into an anonymized disease registry. Data collection will be web-based, and forms part of the project's Virtual Research and Information Environment (VRIE). Participants who haven't undergone genetic diagnostic testing for their condition will be able to do so via the project. CONCLUSIONS: The registry data will be used to increase the understanding of the natural history of WABB diseases, to serve as an evidence base for clinical management, and to aid the identification of opportunities for intervention to stop or delay the progress of the disease. The detailed clinical characterisation will allow inclusion of patients into studies of novel treatment interventions, including targeted interventions in small scale open label studies; and enrolment into multi-national clinical trials. The registry will also support wider access to genetic testing, and encourage international collaborations for patient benefit.
  • Item
    Thumbnail Image
    Novel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index.
    Hoggart, CJ ; Venturini, G ; Mangino, M ; Gomez, F ; Ascari, G ; Zhao, JH ; Teumer, A ; Winkler, TW ; Tšernikova, N ; Luan, J ; Mihailov, E ; Ehret, GB ; Zhang, W ; Lamparter, D ; Esko, T ; Macé, A ; Rüeger, S ; Bochud, P-Y ; Barcella, M ; Dauvilliers, Y ; Benyamin, B ; Evans, DM ; Hayward, C ; Lopez, MF ; Franke, L ; Russo, A ; Heid, IM ; Salvi, E ; Vendantam, S ; Arking, DE ; Boerwinkle, E ; Chambers, JC ; Fiorito, G ; Grallert, H ; Guarrera, S ; Homuth, G ; Huffman, JE ; Porteous, D ; Generation Scotland Consortium, ; LifeLines Cohort study, ; GIANT Consortium, ; Moradpour, D ; Iranzo, A ; Hebebrand, J ; Kemp, JP ; Lammers, GJ ; Aubert, V ; Heim, MH ; Martin, NG ; Montgomery, GW ; Peraita-Adrados, R ; Santamaria, J ; Negro, F ; Schmidt, CO ; Scott, RA ; Spector, TD ; Strauch, K ; Völzke, H ; Wareham, NJ ; Yuan, W ; Bell, JT ; Chakravarti, A ; Kooner, JS ; Peters, A ; Matullo, G ; Wallaschofski, H ; Whitfield, JB ; Paccaud, F ; Vollenweider, P ; Bergmann, S ; Beckmann, JS ; Tafti, M ; Hastie, ND ; Cusi, D ; Bochud, M ; Frayling, TM ; Metspalu, A ; Jarvelin, M-R ; Scherag, A ; Smith, GD ; Borecki, IB ; Rousson, V ; Hirschhorn, JN ; Rivolta, C ; Loos, RJF ; Kutalik, Z ; Visscher, PM (Public Library of Science (PLoS), 2014-07)
    The phenotypic effect of some single nucleotide polymorphisms (SNPs) depends on their parental origin. We present a novel approach to detect parent-of-origin effects (POEs) in genome-wide genotype data of unrelated individuals. The method exploits increased phenotypic variance in the heterozygous genotype group relative to the homozygous groups. We applied the method to >56,000 unrelated individuals to search for POEs influencing body mass index (BMI). Six lead SNPs were carried forward for replication in five family-based studies (of ∼4,000 trios). Two SNPs replicated: the paternal rs2471083-C allele (located near the imprinted KCNK9 gene) and the paternal rs3091869-T allele (located near the SLC2A10 gene) increased BMI equally (beta = 0.11 (SD), P<0.0027) compared to the respective maternal alleles. Real-time PCR experiments of lymphoblastoid cell lines from the CEPH families showed that expression of both genes was dependent on parental origin of the SNPs alleles (P<0.01). Our scheme opens new opportunities to exploit GWAS data of unrelated individuals to identify POEs and demonstrates that they play an important role in adult obesity.
  • Item
    Thumbnail Image
    Role of Endocrine Gland-Derived Vascular Endothelial Growth Factor (EG-VEGF) and Its Receptors in Adrenocortical Tumors
    Heck, D ; Wortmann, S ; Kraus, L ; Ronchi, CL ; Sinnott, RO ; Fassnacht, M ; Sbiera, S (SPRINGER, 2015-12)
    Angiogenesis is essential for tumor growth and metastasis. Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) is an angiogenic factor predominantly expressed in steroidogenic organs like the adrenal gland, ovary, testes, and placenta. EG-VEGF has antiapoptotic, mitogenic, and chemoattractive properties mediated via the two G protein-coupled receptors prokineticin receptor 1 (PKR1) and prokineticin receptor 2 (PKR2). We investigated the expression of EG-VEGF and its receptors in a large number of normal adrenal glands (NAG), adrenocortical adenomas (ACA), and carcinomas (ACC) using real-time PCR (NAG, n = 12; ACA, n = 24; and ACC, n = 30) and immunohistochemistry (NAG, n = 9; ACA, n = 23; and ACC, n = 163) and evaluated its impact on patients' survival. EG-VEGF, PKR1, and PKR2 mRNA and protein are expressed in NAG and the vast majority of ACA and ACC samples. The mean EG-VEGF mRNA expression was significantly lower in ACC (606.5 ± 77.1 copies) compared to NAG (4,043 ± 1,111) and cortisol-producing adenomas (CPA) (4,433 ± 2,378) (p < 0.01 and p < 0.05, respectively). However, cytoplasmic and nuclear EG-VEGF protein expression was either significantly higher or similar in ACC (H score 2.4 ± 0.05, p < 0.05 and 1.7 ± 0.08, n.s., respectively) compared to NAG (1.8 ± 0.14 and 1.7 ± 0.2). Nuclear protein expression of either EG-VEGF or PKR1 or both is predictive for a higher mortality compared to patients without nuclear expression (hazard ratio (HR) = 5.15; 95% confidence interval (CI) = 1.24-21.36, n = 100, p = 0.02 independent of age, sex, and tumor stage). These findings suggest that EG-VEGF and its receptor PKR1 might play a role in the pathogenesis of adrenocortical tumors and could serve as prognostic markers for this rare malignant disease.
  • Item
    Thumbnail Image
    Modeling coordinated multiple views of heterogenous data cubes for urban visual analystics
    Widjaja, I ; Russo, P ; PETTIT, C ; Sinnott, R ; Tomko, M (Taylor & Francis, 2015)
  • Item
    Thumbnail Image
    The Australian Urban Intelligence Network Supporting Smart Cities
    Pettit, C ; Barton, J ; Goldie, X ; Sinnott, R ; Stimson, R ; Kvan, T ; Geertman, S ; Ferreira, J ; Goodspeed, R ; Stillwell, J (Springer International Publishing, 2015)
  • Item
    Thumbnail Image
    Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes
    Penno, MAS ; Couper, JJ ; Craig, ME ; Colman, PG ; Rawlinson, WD ; Cotterill, AM ; Jones, TW ; Harrison, LC (BMC, 2013-08-14)
    BACKGROUND: The incidence of type 1 diabetes has increased worldwide, particularly in younger children and those with lower genetic susceptibility. These observations suggest factors in the modern environment promote pancreatic islet autoimmunity and destruction of insulin-producing beta cells. The Environmental Determinants of Islet Autoimmunity (ENDIA) Study is investigating candidate environmental exposures and gene-environment interactions that may contribute to the development of islet autoimmunity and type 1 diabetes. METHODS/DESIGN: ENDIA is the only prospective pregnancy/birth cohort study in the Southern Hemisphere investigating the determinants of type 1 diabetes in at-risk children. The study will recruit 1,400 unborn infants or infants less than six months of age with a first-degree relative (i.e. mother, father or sibling) with type 1 diabetes, across five Australian states. Pregnant mothers/infants will be followed prospectively from early pregnancy through childhood to investigate relationships between genotype, the development of islet autoimmunity (and subsequently type 1 diabetes), and prenatal and postnatal environmental factors. ENDIA will evaluate the microbiome, nutrition, bodyweight/composition, metabolome-lipidome, insulin resistance, innate and adaptive immune function and viral infections. A systems biology approach will be used to integrate these data. Investigation will be by 3-monthly assessments of the mother during pregnancy, then 3-monthly assessments of the child until 24 months of age and 6-monthly thereafter. The primary outcome measure is persistent islet autoimmunity, defined as the presence of autoantibodies to one or more islet autoantigens on consecutive tests. DISCUSSION: Defining gene-environment interactions that initiate and/or promote destruction of the insulin-producing beta cells in early life will inform approaches to primary prevention of type 1 diabetes. The strength of ENDIA is the prospective, comprehensive and frequent systems-wide profiling from early pregnancy through to early childhood, to capture dynamic environmental exposures that may shape the development of islet autoimmunity. TRIAL REGISTRATION: Australia New Zealand Clinical Trials Registry ACTRN12613000794707.
  • Item
    No Preview Available
    Changes Over Time in Sex Assignment for Disorders of Sex Development
    Kolesinska, Z ; Ahmed, SF ; Niedziela, M ; Bryce, J ; Molinska-Glura, M ; Rodie, M ; Jiang, J ; Sinnott, RO ; Hughes, IA ; Darendeliler, F ; Hiort, O ; van der Zwan, Y ; Cools, M ; Guran, T ; Holterhus, P-M ; Bertelloni, S ; Lisa, L ; Arlt, W ; Krone, N ; Ellaithi, M ; Balsamo, A ; Mazen, I ; Nordenstrom, A ; Lachlan, K ; Alkhawari, M ; Chatelain, P ; Weintrob, N (AMER ACAD PEDIATRICS, 2014-09)
    BACKGROUND AND OBJECTIVE: It is unclear whether the proportion of infants with a disorder of sex development who are raised as male or female has changed over time. The temporal trends in sex assignment of affected cases entered in the International Disorder of Sex Development (I-DSD) Registry were studied. METHODS: Cases of disorders of sex development reported as partial androgen insensitivity syndrome (PAIS; n = 118), disorder of gonadal development (DGD; n = 232), and disorder of androgen synthesis (DAS; n = 104) were divided into those who were born before 1990, 1990-1999, and after 1999. External appearance of the genitalia was described by the external masculinization score. RESULTS: The median (5th-95th percentile) external masculinization scores of those infants with PAIS, DGD, and DAS who were raised as boys were 6 (2-9), 6 (3-9), and 6 (1-12), respectively, and were significantly higher than in those raised as girls (2 [0-6], 2 [0-7], and 0 [0-5], respectively); this difference was maintained in the 3 temporal birth cohorts (P < .01). Of the 118 cases in the pre-1990 cohort, 41 (35%) were raised as boys; of the 148 cases in the 1990-1999 cohort, 60 (41%) were raised as boys; and of the 188 cases in the post-1999 cohort, 128 (68%) were raised as boys. CONCLUSIONS: Although there is an association between the external appearance of the genitalia and the choice of sex assignment, there are clear temporal trends in this practice pointing toward an increased likelihood of affected infants being raised as boys. The impact of this change in practice on long-term health outcomes requires additional focus.
  • Item
    Thumbnail Image
    Novel Associations in Disorders of Sex Development: Findings From the I-DSD Registry
    Cox, K ; Bryce, J ; Jiang, J ; Rodie, M ; Sinnott, R ; Alkhawari, M ; Arlt, W ; Audi, L ; Balsamo, A ; Bertelloni, S ; Cools, M ; Darendeliler, F ; Drop, S ; Ellaithi, M ; Guran, T ; Hiort, O ; Holterhus, P-M ; Hughes, I ; Krone, N ; Lisa, L ; Morel, Y ; Soder, O ; Wieacker, P ; Ahmed, SF (ENDOCRINE SOC, 2014-02)
    CONTEXT: The focus of care in disorders of sex development (DSD) is often directed to issues related to sex and gender development. In addition, the molecular etiology remains unclear in the majority of cases. OBJECTIVE: To report the range of associated conditions identified in the international DSD (I-DSD) Registry. DESIGN, SETTING, AND PATIENTS: Anonymized data were extracted from the I-DSD Registry for diagnosis, karyotype, sex of rearing, genetic investigations, and associated anomalies. If necessary, clarification was sought from the reporting clinician. RESULTS: Of 649 accessible cases, associated conditions occurred in 168 (26%); 103 (61%) cases had one condition, 31 (18%) had two conditions, 20 (12%) had three conditions, and 14 (8%) had four or more conditions. Karyotypes with most frequently reported associations included 45,X with 6 of 8 affected cases (75%), 45,X/46,XY with 19 of 42 cases (45%), 46,XY with 112 of 460 cases (24%), and 46,XX with 27 of 121 cases (22%). In the 112 cases of 46,XY DSD, the commonest conditions included small for gestational age in 26 (23%), cardiac anomalies in 22 (20%), and central nervous system disorders in 22 (20%), whereas in the 27 cases of 46,XX DSD, skeletal and renal anomalies were commonest at 12 (44%) and 8 (30%), respectively. Of 170 cases of suspected androgen insensitivity syndrome, 19 (11%) had reported anomalies and 9 of these had confirmed androgen receptor mutations. CONCLUSIONS: Over a quarter of the cases in the I-DSD Registry have an additional condition. These associations can direct investigators toward novel genetic etiology and also highlight the need for more holistic care of the affected person.
  • Item
    Thumbnail Image
    Biochemical diagnosis of phaeochromocytoma using plasma- free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions
    Daerr, R ; Pamporaki, C ; Peitzsch, M ; Miehle, K ; Prejbisz, A ; Peczkowska, M ; Weismann, D ; Beuschlein, F ; Sinnott, R ; Bornstein, SR ; Neumann, HP ; Januszewicz, A ; Lenders, J ; Eisenhofer, G (WILEY, 2014-04)
    OBJECTIVE: To document the influences of blood sampling under supine fasting versus seated nonfasting conditions on diagnosis of phaeochromocytomas and paragangliomas (PPGL) using plasma concentrations of normetanephrine, metanephrine and methoxytyramine. DESIGN AND METHODS: Biochemical testing for PPGL was performed on 762 patients at six centres, two of which complied with requirements for supine sampling after an overnight fast and four of which did not. Phaeochromocytomas and paragangliomas were found in 129 patients (67 noncompliant, 62 compliant) and not in 633 patients (195 noncompliant, 438 compliant). RESULTS: Plasma concentrations of normetanephrine and methoxytyramine did not differ between compliant and noncompliant sampling conditions in patients with PPGL but were 49-51% higher in patients without PPGL sampled under noncompliant compared with compliant conditions. The 97·5 percentiles of distributions were also higher under noncompliant compared with compliant conditions for normetanephrine (1·29 vs 0·79 nmol/l), metanephrine (0·49 vs 0·41 nmol/l) and methoxytyramine (0·42 vs 0·18 nmol/l). Use of upper cut-offs established from seated nonfasting sampling conditions resulted in substantially decreased diagnostic sensitivity (98% vs 85%). In contrast, use of upper cut-offs established from supine fasting conditions resulted in decreased diagnostic specificity for testing under noncompliant compared with compliant conditions (71% vs 95%). CONCLUSIONS: High diagnostic sensitivity of plasma normetanephrine, metanephrine and methoxytyramine for the detection of PPGL can only be guaranteed using upper cut-offs of reference intervals established with blood sampling under supine fasting conditions. With such cut-offs, sampling under seated nonfasting conditions can lead to a 5·7-fold increase in false-positive results necessitating repeat sampling under supine fasting conditions.
  • Item
    Thumbnail Image
    Deaths by suicide and their relation to general and psychiatric hospital discharge: 30 year record linkage study
    Dougall, Nadine ; Lambert, Paul ; Maxwell, Margaret ; Dawson, Alison ; SINNOTT, RICHARD ; McCafferty, Susan ; Morris, Carole ; CLARK, DAVID ; Springbett, Anthea (The Royal College of Psychiatrists, 2013)
    Background: Studies have rarely explored suicides completed following discharge from pooled hospital settings. Such research might identify additional opportunities for intervention.